FIGURE 3
Percentage of informative tumors with loss of heterozygosity at markers located centromeric to PTEN/MMAC1 (left panel), at intragenic PTEN/MMAC1 markers (center panel), and at markers located telomeric to PTEN/MMAC1 (right panel).
FIGURE 3 | Modern Pathology
